Share-based Compensation (Tables)

6 Months Ended

Dec. 31, 2020

Share-based Compensation

Schedule of weighted average assumptions

	Six Months Ended
	December 31, 2020			December 31, 2019
Risk-free interest rate		0.2	%		1.9	%
Expected volatility		82.5	%		73.7	%
Expected dividend yield		—	%		—	%
Forfeiture rate		—	%		—	%
Expected term		5.0	years		5.1	years
Weighted average fair value	$	3.86		$	4.04

Summary of stock option award activity

						Weighted
		Weighted-				Average
		Average		Aggregate		Remaining
		Exercise		Intrinsic		Contractual
(In thousands, except for weighted average price and life data)	Awards	Price		Value		Life (yrs.)
Outstanding at June 30, 2020	991	$	12.11	$	678	5.6
Granted	309	$	5.95
Exercised	(37)	$	4.12	$	61
Forfeited, expired or repurchased	(217)	$	17.14
Outstanding at December 31, 2020	1,046	$	9.52	$	313	7.7
Vested and expected to vest at December 31, 2020	1,045	$	9.52	$	313	7.7
Exercisable at December 31, 2020	373	$	14.59	$	137	5.3

Summary of non-vested restricted stock awards

		Weighted
		Average Grant -		Aggregate
(In thousands, except for weighted average price data)	Awards	date Fair Value		Intrinsic Value
Non-vested at June 30, 2020	1,344	$	8.70
Granted	876		5.73
Vested	(778)		8.30	$	4,514
Forfeited	(70)		9.46
Non-vested at December 31, 2020	1,372	$	6.99

Schedule of non-vested performance-based shares

		Weighted
		Average Grant -
(In thousands, except for weighted average price and life data)	Awards	date Fair Value
Non-vested at June 30, 2020	204	$	12.99
Granted	339	$	9.22
Performance adjustment (1)	(12)	$	25.58
Non-vested at December 31, 2020	531	$	10.29

(1) Represents the adjustment based on the performance of the September 2017 awards, which was below the Threshold goal level at the end of the three-year performance period.

Schedule of allocation of share-based compensation

	Three Months Ended				Six Months Ended
	December 31,				December 31,
(In thousands)	2020		2019		2020		2019
Selling, general and administrative expenses	$	1,507	$	1,205	$	4,221	$	4,840
Research and development expenses		132		214		287		438
Cost of sales		352		588		825		1,188
Total	$	1,991	$	2,007	$	5,333	$	6,466
Tax benefit at statutory rate	$	448	$	452	$	1,200	$	1,455